Dr. Benjamin Schrank explains his recent research on a first-in-class antibody-drug conjugate that…
@UTMDAnderson142K followers
11,321 views #ASTRO24 #EndCancer
4 Comments
Comments from the original post on X (Twitter)

@BettyKimLab
@BenjaminSchrank @BenjaminSchrank is without a doubt one of the very best physician scientist trainee I have ever encountered. Quadruple threat: great scientist, leadership skills, gifted educator and super kind/humble. Truly exceptional. He’s also on the job market. So proud!
20 likes

@BenjaminSchrank
Thankful to @BettyKimLab and @wenjiang_nano for their continued mentorship and support!
10 likes

@sciqst
Dr. Schrank's research on the antibody-drug conjugate sounds promising, especially as a complement to radiation therapy. By triggering an immune response, it could enhance the overall effectiveness of cancer treatments – potentially improving patient outcomes. How does this conjugate specifically interact with the immune system compared to other immunotherapies? For those interested in more detailed biomedical insights or reviews, check out – your one-stop platform for every biomedical question. #Medicine #CancerResearch #Immunotherapy

@motherofswans
@BenjaminSchrank 👏 LFG! Help me live! #NSCLC #EGFR #OligoBrainMets
